Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Thyroid Cancer, Papillary 1 Sarcoma 1 Pancreatic carcinoma, familial 1 Pancreatic Intraductal Neoplasms 1 Glioma 1 Glioblastoma 1 Esophageal Neoplasms 1 Colorectal Neoplasms 1 Carcinoma, Medullary 1 Cancer of Lymph Node 1 Brain Neoplasms 1 Adult Brain Glioblastoma 1

Interventions

Ifosfamide 8 Doxorubicin 8 Blood Specimen Collection 8 Radiosurgery 7 Proton Therapy 5 Surveys and Questionnaires 4 Surgical Procedures, Operative 4 Standard of Care 4 Radiotherapy 4 Magnetic Resonance Spectroscopy 4 X-Rays 3 Vincristine 3 Radiation Dose Hypofractionation 3 Palliative Care 3 Methods 3 Mesna 3 pegfilgrastim 2 pazopanib 2 dexamethasone acetate 2 Trastuzumab 2 Transurethral Resection of Bladder 2 Restraint, Physical 2 Radiotherapy, Intensity-Modulated 2 Protons 2 Practice Guidelines as Topic 2 Neoadjuvant Therapy 2 Methotrexate 2 Melphalan 2 Heavy Ion Radiotherapy 2 Gene Expression Profiling 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Sarcoma × Ferrosoferric Oxide × Clear all

NCT01663090 2020-10-19

Ferumoxytol-Enhanced MRI in Adult/Pedi Sarcomas

Dana-Farber Cancer Institute

Phase NA Withdrawn

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡